AGBA Acquisition (AGBAW) has had the highest return since January 1, 2024 by a US stock, returning 2,908.2%.
ASSET | % RETURN |
---|---|
AGBA Acquisition (AGBAW) | 2,908.2% |
Nexalin Technology (NXLIW) | 2,412.68% |
Spectaire (SPECW) | 1,138.33% |
Palladyne AI (PDYNW) | 999% |
Onconova Therapeutics (ONTX) | 986.15% |
Binah Capital Group, Inc Warrants (BCGWW) | 943.48% |
LENZ Therapeutics (LENZ) | 771.35% |
Inception Growth Acquisition Limited Warrants (IGTAW) | 755.26% |
Codere Online Luxembourg SA Warrants (CDROW) | 748.66% |
Breeze Holdings Acquisition (BREZW) | 723.08% |
AdTheorent (ADTHW) | 719.8% |
Janone (JAN) | 680.18% |
Airship AI (AISPW) | 677.54% |
Elevation Oncology (ELEV) | 650% |
SRAX (SRAX) | 564.34% |
Rail Vision Ltd Warrant (RVSNW) | 555.74% |
Digital Health Acquisition Corp Warrant (DHACW) | 547.04% |
Liberty Resources Acquisition Corp Warrant (LIBYW) | 542% |
NorthView Acquisition Corporation Warrant (NVACW) | 540% |
PHP Ventures Acquisition Corp Warrants (PPHPW) | 530% |
Swvl (SWVL) | 527.5% |
Corbus Pharmaceuticals (CRBP) | 527.29% |
Zivo Bioscience (ZIVO) | 492.59% |
Bone Biologics Corp Warrants (BBLGW) | 490.92% |
Fitell Corporation Ordinary Shares (FTEL) | 489.47% |